Table 5.
Symptoms at admission and discharge of the total intention-to-treat-sample and patients with and without migratory background in comparison.
| T0 | T1 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total sample (N=263) M (SD) |
Patients without MB (N=208) M (SD) |
Patients with MB (N=55) M (SD) |
Comparison | Total sample (N=256) M (SD) |
Patients without MB (N=204) M (SD) | Patients with MB (N=52) M (SD) |
Comparison | |||||
| T | p | d | T | p | d | |||||||
| PHQ-15 | 12.9 (5.6) | 12.5 (5.6) | 14.5 (5.7) | -2.254 | 0.025 | 0.345 | 11.4 (5.4) | 10.9 (5.1) | 13.5 (6.0) | -3.258 | 0.001 | 0.507 |
| PHQ-15* | 12.5 (5.4) | 12.2 (5.4) | 13.9 (5.4) | -2.118 | 0.035 | 0.324 | 11.0 (5.1) | 10.5 (4.9) | 13.0 (5.6) | -3.077 | 0.002 | 0.478 |
| PHQ-9 | 14.4 (5.7) | 14.1 (5.8) | 15.5 (5.3) | -1.568 | 0.118 | 0.238 | 10.4 (5.7) | 10.1 (5.8) | 11.8 (5.4) | -2.014 | 0.045 | 0.313 |
| GAD-7 | 11.3 (5.1) | 11.0 (5.2) | 12.1 (4.5) | -1.224 | 0.222 | 0.208 | 8.2 (4.9) | 7.8 (4.9) | 9.9 (4.7) | -2.527 | 0.012 | 0.428 |
| PCL-5 | 33.3 (18.7) | 31.6 (18.3) | 39.4 (19.2) | -2.679 | 0.008 | 0.424 | 29.4 (19.8) | 28.0 (19.4) | 34.5 (20.4) | -2.062 | 0.040 | 0.329 |
MB, migratory background; PHQ-15, Patient Health Questionnaire Somatization Module;* without Menstruation Item; PHQ-9, Patient Health Questionnaire Depression Module; GAD-7, General Anxiety Disorder Short Scale; PCL-5, PTSD-Checklist for DSM-5; Varying sample sizes; significant p-values and the corresponding effect sizes are marked in bold.